Found: 219
Select item for more details and to access through your institution.
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐O trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 6080, doi. 10.1111/dom.15957
- By:
- Publication type:
- Article
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
- Published in:
- Diabetologia, 2024, v. 67, n. 11, p. 2585, doi. 10.1007/s00125-024-06251-z
- By:
- Publication type:
- Article
Access to emergency room for hypoglycaemia in people with diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality: a study in Tuscany, Italy, over years 2004-2011.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 280, doi. 10.1002/dmrr.2607
- By:
- Publication type:
- Article
The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2010, v. 26, n. 4, p. 239, doi. 10.1002/dmrr.1092
- By:
- Publication type:
- Article
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2010, v. 26, n. 3, p. 181, doi. 10.1002/dmrr.1069
- By:
- Publication type:
- Article
ß-cell function and anti-diabetic pharmacotherapy.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2007, v. 23, n. 7, p. 518, doi. 10.1002/dmrr.770
- By:
- Publication type:
- Article
Effects of C-peptide on isolated human pancreatic islet cells.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2007, v. 23, n. 3, p. 215, doi. 10.1002/dmrr.674
- By:
- Publication type:
- Article
Improved insulin secretory function and reduced chemotactic properties after tissue culture of islets from type 1 diabetic patients.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 3, p. 246, doi. 10.1002/dmrr.460
- By:
- Publication type:
- Article
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.
- Published in:
- 2001
- By:
- Publication type:
- journal article
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 8, p. 941, doi. 10.1007/s00592-024-02300-6
- By:
- Publication type:
- Article
An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 1, p. 131, doi. 10.1007/s00592-023-02171-3
- By:
- Publication type:
- Article
De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 1, p. 53, doi. 10.1007/s00592-022-01974-0
- By:
- Publication type:
- Article
A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules.
- Published in:
- Science Robotics, 2021, v. 6, n. 57, p. 1, doi. 10.1126/scirobotics.abh3328
- By:
- Publication type:
- Article
The incretin/glucagon system as a target for pharmacotherapy of obesity.
- Published in:
- Obesity Reviews, 2022, v. 23, n. 2, p. 1, doi. 10.1111/obr.13372
- By:
- Publication type:
- Article
Type 2 diabetes mellitus: focus on new treatments and special populations.
- Published in:
- 2007
- By:
- Publication type:
- Other
Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-0991-1
- By:
- Publication type:
- Article
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. 1, doi. 10.1186/s12933-019-0961-7
- By:
- Publication type:
- Article
Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. 1, doi. 10.1186/s12933-019-0951-9
- By:
- Publication type:
- Article
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12933-018-0720-1
- By:
- Publication type:
- Article
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study.
- Published in:
- European Psychiatry, 2021, v. 64, n. 1, p. 1, doi. 10.1192/j.eurpsy.2020.115
- By:
- Publication type:
- Article
Unlocking the opportunity of tight glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, p. S1, doi. 10.1111/j.1463-1326.2005.00528.x
- By:
- Publication type:
- Article
A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2017, p. 1, doi. 10.1155/2017/1026268
- By:
- Publication type:
- Article
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2013, v. 6, p. 161, doi. 10.2147/DMSO.S28951
- By:
- Publication type:
- Article
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2009, v. 2, p. 1
- By:
- Publication type:
- Article
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes.
- Published in:
- Vascular Health & Risk Management, 2014, v. 10, p. 465, doi. 10.2147/VHRM.S40097
- By:
- Publication type:
- Article
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired [beta]-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02432-7
- By:
- Publication type:
- Article
Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02378-w
- By:
- Publication type:
- Article
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02171-9
- By:
- Publication type:
- Article
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-024-02135-z
- By:
- Publication type:
- Article
2024: The year to take European action on diabetes to the next level.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1820, doi. 10.1007/s00125-023-05973-w
- By:
- Publication type:
- Article
Women in diabetes research: we can do better. Reply to Bonnefond A [letter].
- Published in:
- 2023
- By:
- Publication type:
- Letter
The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe.
- Published in:
- Diabetologia, 2023, v. 66, n. 2, p. 247, doi. 10.1007/s00125-022-05831-1
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2022, v. 65, n. 12, p. 1925, doi. 10.1007/s00125-022-05787-2
- By:
- Publication type:
- Article
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
- Published in:
- Diabetologia, 2022, v. 65, n. 8, p. 1251, doi. 10.1007/s00125-022-05715-4
- By:
- Publication type:
- Article
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2423, doi. 10.1007/s00125-020-05254-w
- By:
- Publication type:
- Article
How conclusive is the CONCLUDE trial?
- Published in:
- Diabetologia, 2020, v. 63, n. 4, p. 692, doi. 10.1007/s00125-020-05086-8
- By:
- Publication type:
- Article
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
- Published in:
- Diabetologia, 2017, v. 60, n. 6, p. 1102, doi. 10.1007/s00125-017-4251-1
- By:
- Publication type:
- Article
The role of incretin receptor agonists in the treatment of obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4178, doi. 10.1111/dom.15796
- By:
- Publication type:
- Article
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3633, doi. 10.1111/dom.15703
- By:
- Publication type:
- Article
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1714, doi. 10.1111/dom.15479
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1216, doi. 10.1111/dom.15417
- By:
- Publication type:
- Article
Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 177, doi. 10.1111/dom.14599
- By:
- Publication type:
- Article
Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1331, doi. 10.1111/dom.14345
- By:
- Publication type:
- Article
Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 318, doi. 10.1111/dom.14223
- By:
- Publication type:
- Article
Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 245, doi. 10.1111/dom.14192
- By:
- Publication type:
- Article